Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Eleven Biotherapeutics, Inc. | 105,000 | reported | 19 Jun 2019 | tx 6+250,359 |
| BRISTOL MYERS SQUIBB CO | 87,003 | reported | 22 May 2006 | tx 8+113,996−4,904 |
| Alkermes plc. | 53,124 | reported | 14 Jun 2022 | tx 36+391,843−157,010 |
| IOVANCE BIOTHERAPEUTICS, INC. | 51,204 | reported | 10 Jun 2022 | tx 1+51,204 |
| Orexigen Therapeutics, Inc. | 50,000 | reported | 09 Jun 2015 | tx 7+235,000 |
| Black Diamond Therapeutics, Inc. | 38,054 | reported | 15 Mar 2024 | tx 12+103,614 |
| ZEVRA THERAPEUTICS, INC. | 30,000 | reported | 29 May 2025 | tx 4+128,000 |
| INCYTE CORP | 17,768 | reported | 31 Mar 2022 | tx 66+330,432−186,668 |
| Voyager Therapeutics, Inc. | 15,000 | reported | 04 Jun 2020 | tx 5+90,000 |
| ARVINAS, INC. | 9,121 | reported | 15 Jun 2023 | tx 5+58,611 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2025 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 30,000 | 0.00 USD | deriv |
| 13 May 2024 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 39,200 | 0.00 USD | deriv |
| 15 Mar 2024 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 3,253 | 4.54 USD | |
| 15 Dec 2023 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 4,043 | 2.73 USD | |
| 15 Sept 2023 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 2,986 | 3.60 USD | |
| 15 Jun 2023 | GRANT_AWARD | ARVINAS, INC. | 4,121 | 0.00 USD | |
| 15 Jun 2023 | GRANT_AWARD | ARVINAS, INC. | 12,787 | 0.00 USD | deriv |
| 16 Jun 2023 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 5,119 | 2.10 USD | |
| 16 May 2023 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 16,500 | 0.00 USD | deriv |
| 25 Apr 2023 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 22,500 | 0.00 USD | deriv |
| 03 May 2023 | GRANT_AWARD | ZEVRA THERAPEUTICS, INC. | 36,300 | 0.00 USD | deriv |
| 16 Mar 2023 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 6,437 | 1.67 USD | |
| 16 Dec 2022 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 7,167 | 1.50 USD | |
| 16 Sept 2022 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 4,103 | 2.62 USD | |
| 16 Jun 2022 | GRANT_AWARD | ARVINAS, INC. | 10,192 | 0.00 USD | deriv |
| 17 Jun 2022 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 4,060 | 2.03 USD | |
| 14 Jun 2022 | EXERCISE | Alkermes plc. | 7,585 | — | |
| 14 Jun 2022 | EXERCISE | Alkermes plc. | 7,585 | — | deriv |
| 10 Jun 2022 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 51,204 | 0.00 USD | deriv |
| 10 Jun 2022 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 06 Apr 2022 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 31 Mar 2022 | GRANT_AWARD | INCYTE CORP | 249 | 79.42 USD | |
| 31 Dec 2021 | GRANT_AWARD | INCYTE CORP | 260 | 73.40 USD | |
| 23 Dec 2021 | EXERCISE | INCYTE CORP | 20,000 | 73.25 USD | |
| 23 Dec 2021 | SALE | INCYTE CORP | 20,000 | 22.05 USD |
1 purchase reported after at least 12 months of silence — most recent on 11 Mar 2014.